Last update 26 May 2025

Antithrombin Gamma (Genetical Recombination)

Overview

Basic Info

Drug Type
Enzyme
Synonyms
Acoalan, Afucosylated antithrombin, Antithrombin (human variant kw-3357)
+ [6]
Action
inhibitors
Mechanism
prothrombin inhibitors(Prothrombin inhibitors)
Inactive Indication
Originator Organization
Active Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Antithrombin III Deficiency
Japan
03 Jul 2015
Disseminated Intravascular Coagulation
Japan
03 Jul 2015
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pre-EclampsiaPhase 3
Japan
19 Nov 2019
SepsisPhase 3
Japan
01 Jun 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
-
qlirmhfovg(genkvtwvok) = vvbjvasmfk crtzirkcxy (qffktxwnkq )
-
10 Jun 2019
qlirmhfovg(genkvtwvok) = whoaustqgl crtzirkcxy (qffktxwnkq )
Phase 3
222
tmoqoboixt(doemhhjylk) = prduvkwpzw xszerlmwrx (pvvzrbkqqh, 46.6 - 65.8)
Positive
16 Nov 2018
tmoqoboixt(doemhhjylk) = llqyszlktb xszerlmwrx (pvvzrbkqqh, 43.0 - 62.2)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free